Buy & Sell Amedisys Inc (AMED) – Amedisys Inc Price Today
Key Stats
- $3.32BMarket Cap
- HealthSector
- -3M Drawdown
- $3.43BEnterprise Value
- -Dividend Yield
- 29 daysTypical Hold Time
Amedisys Inc (AMED) is currently valued at a market capitalization of $3.32B, with an enterprise value of $3.43B. Over the past 52 weeks, Amedisys Inc has traded between a low of $83.78 and a high of $100.99, highlighting its annual price range. On average, investors hold Amedisys Inc for approximately 29 days, indicating typical investor behavior on the platform.
About Amedisys Inc
Amedisys Inc is a healthcare services company in the United States. The company brings healthcare to the home through the provision of home healthcare services, hospice services, high acuity care segment , and personal care services. The Home Health Segment provides skilled nurses, therapists, and aids to patients' homes throughout the United States, Hospice segment operates many centers designed to provide comfort and support for terminally ill patients, Personal Care Segment provides individuals with assistance in their daily living activities and High acuity care segment can deliver the essential elements of inpatient hospital, SNF care, and palliative care to patients in their homes. A majority of the company's revenue is derived from the Home Health segment.
Most Recent News
Sitryx Therapeutics to present at major healthcare investor conferences in June 2026
Sitryx Therapeutics, a clinical-stage biopharmaceutical company focused on autoimmune and inflammatory diseases, announced its management will participate in three key investor conferences in June 2026: Jefferies Global Healthcare Conference in New Y...
Regeneron shares drop 10% after Phase 3 melanoma trial misses primary endpoint.
Regeneron Pharmaceuticals' stock fell over 10% following the Phase 3 trial results for their melanoma treatment combining fianlimab and cemiplimab. The trial did not achieve statistical significance for the primary endpoint of progression-free surviv...
Auddia highlights $29B AI infrastructure potential via LT350's GPU-powered parking lot data centers.
Auddia Inc. spotlighted the AI infrastructure opportunity of its LT350 subsidiary, referencing a $1.25 billion GPU cloud contract by SharonAI as a market benchmark. LT350's patented design uses parking lot airspace to deploy up to 960,000 GPUs, poten...
